Causal association between cannabis and psychosis: examination of the evidence.
paper
Cited
Public
Unavailable
- Authors
- Arseneault, Louise; Cannon, Mary; Witton, John; Murray, Robin M
- Year
- 2004
- Journal
- The British journal of psychiatry : the journal of mental science
- PMID
- 14754822
- DOI
- 10.1192/bjp.184.2.110
BACKGROUND: Controversy remains as to whether cannabis acts as a causal risk factor for schizophrenia or other functional psychotic illnesses. AIMS: To examine critically the evidence that cannabis causes psychosis using established criteria of causality. METHOD: We identified five studies that included a well-defined sample drawn from population-based registers or cohorts and used prospective measures of cannabis use and adult psychosis. RESULTS: On an individual level, cannabis use confers an overall twofold increase in the relative risk for later schizophrenia. At the population level, elimination of cannabis use would reduce the incidence of schizophrenia by approximately 8%, assuming a causal relationship. Cannabis use appears to be neither a sufficient nor a necessary cause for psychosis. It is a component cause, part of a complex constellation of factors leading to psychosis. CONCLUSIONS: Cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths. Research is needed to understand the mechanisms by which cannabis causes psychosis.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cannabis Use Among Older Adults. | Pravosud V et al. | β | 2025 | β |
| Comprehensive care processes for substance use disorders in adult mental health services: A systematic review. | Reilly J et al. | β | 2025 | β |
| Exploring the impact of drug decriminalization and legalization policies on mental health outcomes: A scoping review. | Mohebbian M et al. | β | 2025 | β |
| Risk Factors for Late-Onset Psychosis: A Case-Control Study. | Skinner JP et al. | β | 2025 | β |
| Semantic Processing Deficits and Their Use as Early Biomarkers in Schizophrenia. | MartΓnez-Cano A et al. | β | 2025 | β |
| Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents. | Li Z et al. | β | 2025 | β |
| The Effects of THC and Nicotine on Attention: A Narrative Review. | Oleszak K et al. | β | 2025 | β |
| Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder. | Ney L | β | 2025 | β |
| [Addictive behavior among teenagers: new trends]. | Phan O | β | 2024 | β |
| A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning. | Karaglani M et al. | β | 2024 | β |
| Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research. | Schoeler T et al. | β | 2024 | β |
| Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review. | White E et al. | β | 2024 | β |
| Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017-2021. | Pravosud V et al. | β | 2024 | β |
| Development and initial validation of the cannabis-related psychosis risk literacy scale (CPRL): a multinational psychometric study. | Fekih-Romdhane F et al. | β | 2024 | β |
| Does cannabis affect cognitive functioning in patients with schizophrenia? | Rachid H et al. | β | 2024 | β |
| Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta-analysis. | Shafiee A et al. | β | 2024 | β |
| Social Media Exposure and Other Correlates of Increased e-Cigarette Use Among Adolescents During Remote Schooling: Cross-Sectional Study. | Pravosud V et al. | β | 2024 | β |
| Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK. | Mulligan LD et al. | β | 2024 | β |
| The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada. | Wootten JC et al. | β | 2024 | β |
| The relationship between substance use and self-reported aspects of social functioning in patients with a psychotic disorder. | van der Heijden HS et al. | β | 2024 | β |
| Using Task-fMRI to Explore the Relationship Between Lifetime Cannabis Use and Cognitive Control in Individuals With First-Episode Schizophrenia. | Lesh TA et al. | β | 2024 | β |
| Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. | Ruffell SGD et al. | β | 2023 | β |
| Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. | Maggu G et al. | β | 2023 | β |
| Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study. | Trotta G et al. | β | 2023 | β |
| Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician's perspective. | Ney LJ et al. | β | 2023 | β |
| Second-generation antipsychotics and metabolic syndrome: a role for mitochondria. | Mortimer KRH et al. | β | 2023 | β |
| Sleep disturbance after cessation of cannabis administration inΒ mice. | Asano T et al. | β | 2023 | β |
| State Cannabis Legalization and Psychosis-Related Health Care Utilization. | Elser H et al. | β | 2023 | β |
| The effect of schizophrenia risk factors on mismatch responses in a rat model. | Jalewa J et al. | β | 2023 | β |
| Cannabidiol for at risk for psychosis youth: A randomized controlled trial. | Amminger GP et al. | β | 2022 | β |
| Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms. | Carvalho C et al. | β | 2022 | β |
| Explaining the Association Between Urbanicity and Psychotic-Like Experiences in Pre-Adolescence: The Indirect Effect of Urban Exposures. | Saxena A et al. | β | 2022 | β |
| Online Knowledge Translation Program Involving Video Games and University Student-Led Tutorials About Cannabis and Psychosis for Black Youth: Mixed Method Feasibility Study. | Jani P et al. | β | 2022 | β |
| Psychiatric disorders and associated risk factors in a sample of adolescents in Gaborone, Botswana: a cross-sectional study. | Olashore AA et al. | β | 2022 | β |
| Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications. | Holdman R et al. | β | 2022 | β |
| Shifting the Paradigm on Cannabis Safety. | Bannigan P et al. | β | 2022 | β |
| 'The Drug Survey App': a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. | Conigrave JH et al. | β | 2022 | β |
| Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review. | Kaur N et al. | β | 2022 | β |
| Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice. | Kruk-Slomka M et al. | β | 2021 | β |
| Cannabis use, attitudes, regulation and health: Survey data from an urban population of users and non-users. | Znoj H et al. | β | 2021 | β |
| Cigarette smoking as a risk factor for schizophrenia or all non-affective psychoses. | King M et al. | β | 2021 | β |
| Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions. | Robinson N et al. | β | 2021 | β |
| Eye movements in patients in early psychosis with and without a history of cannabis use. | Sami MB et al. | β | 2021 | β |
| Gender differences in the experience of psychotic-like experiences and their associated factors: A study of adolescents from the general population. | Stainton A et al. | β | 2021 | β |
| Serotonin 2A receptors and cannabinoids. | Ibarra-Lecue I et al. | β | 2021 | β |
| The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review. | Takakuwa KM et al. | β | 2021 | β |
| Youth marijuana use: a review of causes and consequences. | Scheier LM et al. | β | 2021 | β |
| Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models. | Dunn AL et al. | β | 2020 | β |
| Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus. | Blest-Hopley G et al. | β | 2020 | β |
| Association between polygenic liability for schizophrenia and substance involvement: A nationwide population-based study in Taiwan. | Wang SH et al. | β | 2020 | β |
| Cannabis Use and the Risk for Psychosis and Affective Disorders. | Sideli L et al. | β | 2020 | β |
| Cannabis Use Disorder Among First-Year Undergraduate Students in Gaborone, Botswana. | Olashore AA et al. | β | 2020 | β |
| Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. | Roncero C et al. | β | 2020 | β |
| Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review. | Farris MS et al. | β | 2020 | β |
| Childhood trauma and substance use underlying psychosis: a systematic review. | SetiΓ©n-Suero E et al. | β | 2020 | β |
| Early 5-HT<sub>6</sub> receptor blockade prevents symptom onset in a model of adolescent cannabis abuse. | Berthoux C et al. | β | 2020 | β |
| Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review. | van der Steur SJ et al. | β | 2020 | β |
| [Neurodevelopment and cannabis]. | Krebs MO et al. | β | 2020 | β |
| Psychological interventions for psychosis in adolescents. | Datta SS et al. | β | 2020 | β |
| Role of cannabis in inflammatory bowel diseases. | Perisetti A et al. | β | 2020 | β |
| Adolescent exposure to Ξ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood. | Abela AR et al. | β | 2019 | β |
| Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. | Krebs MO et al. | β | 2019 | β |
| Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis. | Nettis MA et al. | β | 2019 | β |
| Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort. | SetiΓ©n-Suero E et al. | β | 2019 | β |
| Ξ<sup>9</sup>-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. | Lecca S et al. | β | 2019 | β |
| Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility. | Aguilar DD et al. | β | 2018 | β |
| Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. | Sami MB et al. | β | 2018 | β |
| Cannabis consumption and psychosis or schizophrenia development. | Ortiz-Medina MB et al. | β | 2018 | β |
| Cannabis Use Among Remote Indigenous Australians: Opportunities to Support Change Identified in Two Waves of Sampling. | Graham VE et al. | β | 2018 | β |
| Cannabis Use, Psychotic Like Experiences and Aberrant Salience in a Sample of Belgian Students. | Bernardini F et al. | β | 2018 | β |
| Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. | Wilson L et al. | β | 2018 | β |
| Commentary on Degenhardt et al. (2018): Cause or consequence? Disentangling the relationship between psychosis and substance use. | DeVylder JE et al. | β | 2018 | β |
| Common Substances of Abuse. | Wang GS et al. | β | 2018 | β |
| Does social context matter? An ecological momentary assessment study of marijuana use among college students. | Phillips KT et al. | β | 2018 | β |
| Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders. | RΓΈmer Thomsen K et al. | β | 2018 | β |
| Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology. | Renard J et al. | β | 2018 | β |
| Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use. | Sideli L et al. | β | 2018 | β |
| Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring. | Bolhuis K et al. | β | 2018 | β |
| Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study. | Vuletic D et al. | β | 2018 | β |
| The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis. | Hahn B | β | 2018 | β |
| Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex. | Renard J et al. | β | 2017 | β |
| Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function. | Renard J et al. | β | 2017 | β |
| Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder. | Γstergaard MLD et al. | β | 2017 | β |
| Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins. | NesvΓ₯g R et al. | β | 2017 | β |
| Investigation of the <i>COMT</i> Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. | Lodhi RJ et al. | β | 2017 | β |
| Lipids in psychiatric disorders and preventive medicine. | Schneider M et al. | β | 2017 | β |
| Marijuana use and associated motives in Colorado university students. | Phillips KT et al. | β | 2017 | β |
| Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use. | Mhalla A et al. | β | 2017 | β |
| [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]. | Havemann-Reinecke U et al. | β | 2017 | β |
| Recurrent cannabis use among Norwegian students: Prevalence, characteristics, and polysubstance use. | Erevik EK et al. | β | 2017 | β |
| THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell-Derived Neurons. | Obiorah IV et al. | β | 2017 | β |
| The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice. | Kruk-Slomka M et al. | β | 2017 | β |
| Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids. | Appiah-Kusi E et al. | β | 2016 | β |
| Adverse effects of marijuana use. | Feeney KE et al. | β | 2016 | β |
| Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement. | Carey CE et al. | β | 2016 | β |
| Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. | Xia M et al. | β | 2016 | β |
| Bifeprunox versus placebo for schizophrenia. | Chattopadhyay A et al. | β | 2016 | β |
| Cannabis Use and Associated Harms among Schizophrenia Patients in a Nigerian Clinical Setting: A Case-Control Study. | Lasebikan V et al. | β | 2016 | β |
| Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. | NΓΊΓ±ez C et al. | β | 2016 | β |
| Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. | Kraan T et al. | β | 2016 | β |
| Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex. | Renard J et al. | β | 2016 | β |
| Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. | Schoeler T et al. | β | 2016 | β |
| Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. | Zettl UK et al. | β | 2016 | β |
| Exploring compulsory admission experiences of adults with psychosis in the UK using Grounded Theory. | Loft NO et al. | β | 2016 | β |
| Gene Γ Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. | Moran P et al. | β | 2016 | β |
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | Sherva R et al. | β | 2016 | β |
| Marijuana and Listing for Heart Transplant: A Survey of Transplant Providers. | Neyer J et al. | β | 2016 | β |
| Marijuana Legalization: Impact on Physicians and Public Health. | Wilkinson ST et al. | β | 2016 | β |
| Opioid abuse and hospitalization rates in patients with schizophrenia. | Kivimies K et al. | β | 2016 | β |
| Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. | Woodberry KA et al. | β | 2016 | β |
| Psychosis as a transdiagnostic and extended phenotype in the general population. | van Os J et al. | β | 2016 | β |
| Recreational marijuana use impacts white matter integrity and subcortical (but not cortical) morphometry. | Orr JM et al. | β | 2016 | β |
| The association between cannabis use and anxiety disorders: Results from a population-based representative sample. | Feingold D et al. | β | 2016 | β |
| The association between cannabis use and suicidality among men and women: A population-based longitudinal study. | Shalit N et al. | β | 2016 | β |
| The burden of disease attributable to cannabis use in Canada in 2012. | Imtiaz S et al. | β | 2016 | β |
| The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay. | Johnson JM et al. | β | 2016 | β |
| Use of novel psychoactive substances by inpatients on general adult psychiatric wards. | Stanley JL et al. | β | 2016 | β |
| U-shaped curve of psychosis according to cannabis use: New evidence from a snowball sample. | BraΓ±as A et al. | β | 2016 | β |
| Adverse childhood events and psychosis in bipolar affective disorder. | Upthegrove R et al. | β | 2015 | β |
| An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity. | Lovelace JW et al. | β | 2015 | β |
| Appraising the risks of reefer madness. | Murray R | β | 2015 | β |
| Associations between psychotic symptoms and substance use in young offenders. | Degenhardt L et al. | β | 2015 | β |
| A systematic review of the antipsychotic properties of cannabidiol in humans. | Iseger TA et al. | β | 2015 | β |
| Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report. | HΓ₯kansson A et al. | β | 2015 | β |
| Cannabis and psychosis. | Gage SH et al. | β | 2015 | β |
| Cannabis use and mania symptoms: a systematic review and meta-analysis. | Gibbs M et al. | β | 2015 | β |
| Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threat. | Spechler PA et al. | β | 2015 | β |
| Childhood trauma and schizotypy: a systematic literature review. | Velikonja T et al. | β | 2015 | β |
| Contextual risks linking parents' adolescent marijuana use to offspring onset. | Kerr DC et al. | β | 2015 | β |
| Direction of Effects in Multiple Linear Regression Models. | Wiedermann W et al. | β | 2015 | β |
| Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. | Sami MB et al. | β | 2015 | β |
| Does tobacco use cause psychosis? Systematic review and meta-analysis. | Gurillo P et al. | β | 2015 | β |
| Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation. | Smeets F et al. | β | 2015 | β |
| Friends interventions in psychosis: a narrative review and call to action. | Harrop C et al. | β | 2015 | β |
| Further human evidence for striatal dopamine release induced by administration of β9-tetrahydrocannabinol (THC): selectivity to limbic striatum. | Bossong MG et al. | β | 2015 | β |
| Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Ξ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences. | Tunbridge EM et al. | β | 2015 | β |
| Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users. | Rognli EB et al. | β | 2015 | β |
| Neurodevelopment, GABA system dysfunction, and schizophrenia. | Schmidt MJ et al. | β | 2015 | β |
| Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. | Di Forti M et al. | β | 2015 | β |
| Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. | Fergusson DM et al. | β | 2015 | β |
| Sensorimotor gating, cannabis use and the risk of psychosis. | Winton-Brown T et al. | β | 2015 | β |
| Sensory gating deficits in the attenuated psychosis syndrome. | Shaikh M et al. | β | 2015 | β |
| Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study. | Kendler KS et al. | β | 2015 | β |
| Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. | NesvΓ₯g R et al. | β | 2015 | β |
| Temporal trends of alcohol and drug use among Inuit of Northern Quebec, Canada. | Fortin M et al. | β | 2015 | β |
| The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. | Giordano GN et al. | β | 2015 | β |
| The association between cannabis use and mood disorders: A longitudinal study. | Feingold D et al. | β | 2015 | β |
| The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series. | El-Khoury J et al. | β | 2015 | β |
| The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. | Zhang MW et al. | β | 2015 | β |
| The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document. | Wilsey B et al. | β | 2015 | β |
| What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review. | Gurung R et al. | β | 2015 | β |
| What to make of cannabis and cognition in MS: In search of clarity amidst the haze. | Feinstein A et al. | β | 2015 | β |
| Aetiology of schizophrenia and implications for nursing practice: a literature review. | Cunningham C et al. | β | 2014 | β |
| A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness. | Uher R et al. | β | 2014 | β |
| Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. | Zamberletti E et al. | β | 2014 | β |
| Approach to cannabis use disorder in primary care: focus on youth and other high-risk users. | Turner SD et al. | β | 2014 | β |
| A preliminary comparison of cannabis use in subsyndromal gamblers: select neurocognitive and behavioral differences based on use. | Leppink E et al. | β | 2014 | β |
| A service-level action research intervention to improve identification and treatment of cannabis and related mental health issues in young Indigenous Australians: a study protocol. | Bohanna I et al. | β | 2014 | β |
| Can cannabis be considered a substitute medication for alcohol? | Subbaraman MS | β | 2014 | β |
| Cannabidiol as a potential treatment for psychosis. | Schubart CD et al. | β | 2014 | β |
| Cannabis abuse and age at onset in schizophrenia patients with large, rare copy number variants. | Martin AK et al. | β | 2014 | β |
| Cannabis controversies: how genetics can inform the study of comorbidity. | Agrawal A et al. | β | 2014 | β |
| Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia? | Hill MN | β | 2014 | β |
| Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Ξ9-tetrahydrocannabinol. | Burne TH et al. | β | 2014 | β |
| Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act. | Monaghan M | β | 2014 | β |
| Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: a time series analysis. | Hamilton I et al. | β | 2014 | β |
| Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. | Gomes FV et al. | β | 2014 | β |
| Genetic dissection of the psychotomimetic effects of cannabinoid exposure. | O'Tuathaigh CM et al. | β | 2014 | β |
| Genetic predisposition to schizophrenia associated with increased use of cannabis. | Power RA et al. | β | 2014 | β |
| Gone to Pot - A Review of the Association between Cannabis and Psychosis. | Radhakrishnan R et al. | β | 2014 | β |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. | European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI) et al. | β | 2014 | β |
| Impact of Cannabis Use on the Development of Psychotic Disorders. | Wilkinson ST et al. | β | 2014 | β |
| Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia. | Aguilar DD et al. | β | 2014 | β |
| Influences on Boys' Marijuana Use in High School: A Two-Part Random Intercept Growth Model. | Washburn IJ et al. | β | 2014 | β |
| Latent classes of substance use in adolescent cannabis users: predictors and subsequent substance-related harm. | Fallu JS et al. | β | 2014 | β |
| Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. | Renard J et al. | β | 2014 | β |
| Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia. | Limosin F | β | 2014 | β |
| Perineuronal nets and schizophrenia: the importance of neuronal coatings. | Bitanihirwe BK et al. | β | 2014 | β |
| Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. | Kahan M et al. | β | 2014 | β |
| Prevalence of cannabis residues in psychiatric patients: a case study of two mental health referral hospitals in Uganda. | Awuzu EA et al. | β | 2014 | β |
| Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or β9-tetrahydrocannabinol (THC). | Bossong MG et al. | β | 2014 | β |
| Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. | Mizrahi R et al. | β | 2014 | β |
| Substance use in clinical high risk for psychosis: a review of the literature. | Addington J et al. | β | 2014 | β |
| The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. | SΓ‘nchez-BlΓ‘zquez P et al. | β | 2014 | β |
| The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. | LΓΈberg EM et al. | β | 2014 | β |
| The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. | Iyegbe C et al. | β | 2014 | β |
| The epigenome and postnatal environmental influences in psychotic disorders. | Pishva E et al. | β | 2014 | β |
| The role of cannabinoid 1 receptor expressing interneurons in behavior. | Brown JA et al. | β | 2014 | β |
| Under the influence: informing oral health care providers about substance abuse. | Riemer L et al. | β | 2014 | β |
| ABC Schizophrenia study: an overview of results since 1996. | HΓ€fner H et al. | β | 2013 | β |
| Adolescence as a vulnerable period to alter rodent behavior. | Schneider M | β | 2013 | β |
| Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice. | Raver SM et al. | β | 2013 | β |
| Age at onset of schizophrenia: cannabis, COMT gene, and their interactions. | De Sousa KR et al. | β | 2013 | β |
| Cannabis, psychosis and the thalamus: a theoretical review. | Vukadinovic Z et al. | β | 2013 | β |
| Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. | Paruk S et al. | β | 2013 | β |
| Changes in the diagnosed incidence of early onset schizophrenia over four decades. | Okkels N et al. | β | 2013 | β |
| Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. | Spano MS et al. | β | 2013 | β |
| Commentary on Degenhardt et al. (2013): Specific effect of adolescent cannabis use on anxiety - tentative explanations. | Huizink AC | β | 2013 | β |
| Comorbidity between hypomania and substance use disorders. | Do EK et al. | β | 2013 | β |
| Effects of cannabis use status on cognitive function, in males with schizophrenia. | Rabin RA et al. | β | 2013 | β |
| [Environmental risk factors for schizophrenia: a review]. | Vilain J et al. | β | 2013 | β |
| Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. | Klein J et al. | β | 2013 | β |
| Medical and recreational marijuana: commentary and review of the literature. | Wilkinson ST | β | 2013 | β |
| Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models. | Karl T | β | 2013 | β |
| Pathways from cannabis to psychosis: a review of the evidence. | Burns JK | β | 2013 | β |
| Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs? | Archie S et al. | β | 2013 | β |
| Structural brain alterations associated with schizophrenia preceded by conduct disorder: a common and distinct subtype of schizophrenia? | Schiffer B et al. | β | 2013 | β |
| Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. | Welch KA et al. | β | 2013 | β |
| The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT ValΒΉβ΅βΈMet polymorphism. | Vinkers CH et al. | β | 2013 | β |
| The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. | Degenhardt L et al. | β | 2013 | β |
| The involvement of Reelin in neurodevelopmental disorders. | Folsom TD et al. | β | 2013 | β |
| Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area. | Weibell MA et al. | β | 2013 | β |
| Urbanicity, social adversity and psychosis. | Heinz A et al. | β | 2013 | β |
| Alterations of theory of mind network activation in chronic cannabis users. | Roser P et al. | β | 2012 | β |
| An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. | LΓΈberg EM et al. | β | 2012 | β |
| Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. | Caballero A et al. | β | 2012 | β |
| Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. | Tambaro S et al. | β | 2012 | β |
| Cannabis-induced depersonalization disorder in adolescence. | HΓΌrlimann F et al. | β | 2012 | β |
| Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. | Dragt S et al. | β | 2012 | β |
| Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. | Behan AT et al. | β | 2012 | β |
| Chronic ΞβΉ-tetrahydrocannabinol exposure induces a sensitization of dopamine Dβ/β receptors in the mesoaccumbens and nigrostriatal systems. | Ginovart N et al. | β | 2012 | β |
| Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. | Braga RJ et al. | β | 2012 | β |
| Delayed preattentional functioning in early psychosis patients with cannabis use. | Pesa N et al. | β | 2012 | β |
| Dr mittal and colleagues reply. | Mittal MS et al. | β | 2012 | β |
| Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. | Anglin DM et al. | β | 2012 | β |
| Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. | van Dijk D et al. | β | 2012 | β |
| Extent of illicit drug use and dependence, and their contribution to the global burden of disease. | Degenhardt L et al. | β | 2012 | β |
| Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. | Zamberletti E et al. | β | 2012 | β |
| Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. | O'Tuathaigh CM et al. | β | 2012 | β |
| Infectious agents associated with schizophrenia: a meta-analysis. | Arias I et al. | β | 2012 | β |
| Is parental socio-economic status related to the initiation of substance abuse by young people in an English city? An event history analysis. | Sutherland A | β | 2012 | β |
| Methamphetamine-associated psychosis. | Grant KM et al. | β | 2012 | β |
| Physicians and medical marijuana. | Kleber HD et al. | β | 2012 | β |
| Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. | DesfossΓ©s J et al. | β | 2012 | β |
| Reduced mismatch negativity predates the onset of psychosis. | Shaikh M et al. | β | 2012 | β |
| State of the art treatments for cannabis dependence. | Danovitch I et al. | β | 2012 | β |
| Substance abuse disorders. | Reid AG et al. | β | 2012 | β |
| Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology. | O'Tuathaigh CM et al. | β | 2012 | β |
| The association between social phobia, social anxiety cognitions and paranoid symptoms. | Schutters SI et al. | β | 2012 | β |
| The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. | Leeson VC et al. | β | 2012 | β |
| The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. | YΓΌcel M et al. | β | 2012 | β |
| Young people's beliefs about the harmfulness of alcohol, cannabis and tobacco for mental disorders: findings from two Australian national youth surveys. | Yap MB et al. | β | 2012 | β |
| A case of psychosis after use of a detoxification kit and a review of techniques, risks, and regulations associated with the subversion of urine drug tests. | Mittal MS et al. | β | 2011 | β |
| Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice. | BrzΓ³zka MM et al. | β | 2011 | β |
| Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. | Parkar SR et al. | β | 2011 | β |
| Associations between psychotic-like symptoms and inattention/hyperactivity symptoms. | Hurtig TM et al. | β | 2011 | β |
| A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. | Matheson SL et al. | β | 2011 | β |
| Cannabis and psychometrically-defined schizotypy: use, problems and treatment considerations. | Cohen AS et al. | β | 2011 | β |
| Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. | Estrada G et al. | β | 2011 | β |
| Cannabis use and psychosis: re-visiting the role of childhood trauma. | Houston JE et al. | β | 2011 | β |
| Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study. | Safont G et al. | β | 2011 | β |
| Cannabis use disorder and age at onset of psychosis--a study in first-episode patients. | Schimmelmann BG et al. | β | 2011 | β |
| Cannabis use in young people: the risk for schizophrenia. | Casadio P et al. | β | 2011 | β |
| Cannabis with high cannabidiol content is associated with fewer psychotic experiences. | Schubart CD et al. | β | 2011 | β |
| Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. | Alemany S et al. | β | 2011 | β |
| Childhood trauma and increased stress sensitivity in psychosis. | Lardinois M et al. | β | 2011 | β |
| Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine. | Leweke FM et al. | β | 2011 | β |
| Comorbid psychiatric diagnoses among individuals presenting to an addiction treatment program for alcohol dependence. | Lyne JP et al. | β | 2011 | β |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. | Kuepper R et al. | β | 2011 | β |
| Course of auditory vocal hallucinations in childhood: 5-year follow-up study. | Bartels-Velthuis AA et al. | β | 2011 | β |
| Developmental trajectories of marijuana use from adolescence to adulthood: personality and social role outcomes. | Brook JS et al. | β | 2011 | β |
| Disruption of frontal ΞΈ coherence by Ξ9-tetrahydrocannabinol is associated with positive psychotic symptoms. | Morrison PD et al. | β | 2011 | β |
| Epidemiological fallacies of modern psychiatric research. | Newson RS et al. | β | 2011 | β |
| Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: a computerized experience sampling study. | Ben-Zeev D et al. | β | 2011 | β |
| Genome-wide association study in bipolar patients stratified by co-morbidity. | Kerner B et al. | β | 2011 | β |
| Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia. | Welch KA et al. | β | 2011 | β |
| Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. | Costas J et al. | β | 2011 | β |
| Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. | Molloy C et al. | β | 2011 | β |
| Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. | van Hell HH et al. | β | 2011 | β |
| Poor childhood mental health may explain linkages between trauma, cannabis use and later psychotic experiences. | Daly M | β | 2011 | β |
| Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis. | Malcolm CP et al. | β | 2011 | β |
| The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. | Saha S et al. | β | 2011 | β |
| Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. | Bossong MG et al. | β | 2010 | β |
| Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. | Malone DT et al. | β | 2010 | β |
| Adolescent cannabis use increases risk for cocaine-induced paranoia. | Kalayasiri R et al. | β | 2010 | β |
| Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. | Dragt S et al. | β | 2010 | β |
| An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. | Minozzi S et al. | β | 2010 | β |
| Are genetic variants of COMT associated with addiction? | TammimΓ€ki AE et al. | β | 2010 | β |
| A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development. | Rodrigo C et al. | β | 2010 | β |
| Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. | McLaren JA et al. | β | 2010 | β |
| Beyond the first episode: candidate factors for a risk prediction model of schizophrenia. | Murphy BP | β | 2010 | β |
| Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes. | Mato S et al. | β | 2010 | β |
| Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. | Harley M et al. | β | 2010 | β |
| Cannabis use and cognitive functioning in first-episode schizophrenia patients. | RodrΓguez-SΓ‘nchez JM et al. | β | 2010 | β |
| Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. | Foti DJ et al. | β | 2010 | β |
| Cannabis use disorders in schizophrenia: effects on cognition and symptoms. | DeRosse P et al. | β | 2010 | β |
| Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. | Machielsen M et al. | β | 2010 | β |
| Chronic adolescent exposure to Ξ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. | O'Tuathaigh CM et al. | β | 2010 | β |
| Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment. | Archer T et al. | β | 2010 | β |
| Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. | de Graaf R et al. | β | 2010 | β |
| Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. | Larson MK et al. | β | 2010 | β |
| Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. | Lagerberg TV et al. | β | 2010 | β |
| Exposure to cannabis in popular music and cannabis use among adolescents. | Primack BA et al. | β | 2010 | β |
| [Hallucinations in children and adolescents: diagnostic and treatment strategies]. | Jardri R et al. | β | 2010 | β |
| How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do? | Macleod J et al. | β | 2010 | β |
| Is there a causal linkage between cannabis use and increased risks of psychotic symptoms? | Fergusson DM | β | 2010 | β |
| [Management of patients with substance use illnesses in psychiatric emergency department]. | Amaral RA et al. | β | 2010 | β |
| Neuroimaging in cannabis use: a systematic review of the literature. | MartΓn-Santos R et al. | β | 2010 | β |
| Phytocannabinoids, CNS cells and development: a dead issue? | Downer EJ et al. | β | 2010 | β |
| [Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city]. | Schnell T et al. | β | 2010 | β |
| Psychosis reactivity to cannabis use in daily life: an experience sampling study. | Henquet C et al. | β | 2010 | β |
| Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland. | Kelly BD et al. | β | 2010 | β |
| Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. | Jacobson S et al. | β | 2010 | β |
| Substance use in adolescence and psychosis: clarifying the relationship. | Barkus E et al. | β | 2010 | β |
| Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. | BarrigΓ³n ML et al. | β | 2010 | β |
| The epidemiology of schizophrenia: replacing dogma with knowledge. | Stilo SA et al. | β | 2010 | β |
| Treatment implications of the schizophrenia prodrome. | Kaur T et al. | β | 2010 | β |
| Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. | Fischer B et al. | β | 2010 | β |
| Variable individual sensitivity to cannabis in patients with schizophrenia. | Goldberger C et al. | β | 2010 | β |
| Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis. | Bortolato M et al. | β | 2010 | β |
| What are the policy implications of the evidence on cannabis use and psychosis? | Hall W et al. | β | 2010 | β |
| What every adolescent needs to know: cannabis can cause psychosis. | Shapiro GK et al. | β | 2010 | β |
| Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. | Frisher M et al. | β | 2009 | β |
| Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. | Wegener N et al. | β | 2009 | β |
| Cannabis and anxiety: a critical review of the evidence. | Crippa JA et al. | β | 2009 | β |
| [Cannabis and psychosis: search of a causal link through a critical and systematic review]. | Le Bec PY et al. | β | 2009 | β |
| Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable? | Kimhy D et al. | β | 2009 | β |
| Cannabis and schizophrenia spectrum disorders: a review of clinical studies. | Rodrigo C et al. | β | 2009 | β |
| Cannabis-induced bipolar disorder with psychotic features: a case report. | Khan MA et al. | β | 2009 | β |
| Cannabis use and cognition in schizophrenia. | LΓΈberg EM et al. | β | 2009 | β |
| Choice of environmental components for a longitudinal birth cohort study. | Golding J et al. | β | 2009 | β |
| Clinical characteristics influencing age at onset in psychotic disorders. | OngΓΌr D et al. | β | 2009 | β |
| Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. | Bossong MG et al. | β | 2009 | β |
| Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. | Ashtari M et al. | β | 2009 | β |
| Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. | Basavarajappa BS et al. | β | 2009 | β |
| Epigenetic mediation of environmental influences in major psychotic disorders. | Rutten BP et al. | β | 2009 | β |
| First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. | Crebbin K et al. | β | 2009 | β |
| Genes, cognition and brain through a COMT lens. | Dickinson D et al. | β | 2009 | β |
| [Is cannabis a vulnerability factor in schizophrenic disorders]. | Laqueille X | β | 2009 | β |
| Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms. | Kamali M et al. | β | 2009 | β |
| Measuring outcomes in a longitudinal birth cohort. | Golding J | β | 2009 | β |
| Media exposure and marijuana and alcohol use among adolescents. | Primack BA et al. | β | 2009 | β |
| Prediction of cannabis use disorder between boyhood and young adulthood: clarifying the phenotype and environtype. | Kirisci L et al. | β | 2009 | β |
| Prevalence of psychotic symptoms in substance users: a comparison across substances. | Smith MJ et al. | β | 2009 | β |
| Reprint of "Treatment of cannabis use disorders in people with schizophrenia spectrum disorders--a systematic review". | HjorthΓΈj C et al. | β | 2009 | β |
| Sentinels on the road to disaster. | Tyrer P | β | 2009 | β |
| Should burden of disease estimates include cannabis use as a risk factor for psychosis? | Degenhardt L et al. | β | 2009 | β |
| [Student's use of illicit drugs: a survey in a preventive health service]. | Morvan Y et al. | β | 2009 | β |
| Substance misuse and early psychosis. | Tucker P | β | 2009 | β |
| The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. | Morrison PD et al. | β | 2009 | β |
| The association between early cannabis use and psychotic-like experiences in a community adolescent sample. | Hides L et al. | β | 2009 | β |
| The dopamine hypothesis of schizophrenia: version III--the final common pathway. | Howes OD et al. | β | 2009 | β |
| The endocannabinoid system as a target for modelling psychosis. | Koethe D et al. | β | 2009 | β |
| The genetics of bipolar disorder. | Barnett JH et al. | β | 2009 | β |
| The neurodevelopmental hypothesis of schizophrenia, revisited. | Fatemi SH et al. | β | 2009 | β |
| Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review. | HjorthΓΈj C et al. | β | 2009 | β |
| Understanding and testing risk mechanisms for mental disorders. | Rutter M | β | 2009 | β |
| Who should be studied and when in a longitudinal birth cohort? | Golding J | β | 2009 | β |
| Abnormal P300 in people with high risk of developing psychosis. | Bramon E et al. | β | 2008 | β |
| Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. | Schneider M et al. | β | 2008 | β |
| Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. | Harder VS et al. | β | 2008 | β |
| Cannabis and psychiatric disorders: it is not only addiction. | Leweke FM et al. | β | 2008 | β |
| Cannabis use and genetic predisposition for schizophrenia: a case-control study. | Veling W et al. | β | 2008 | β |
| Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. | Houston JE et al. | β | 2008 | β |
| Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. | HjorthΓΈj C et al. | β | 2008 | β |
| Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. | Karlsgodt KH et al. | β | 2008 | β |
| Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). | Hollis C et al. | β | 2008 | β |
| Drugs, mental health and the adolescent brain: implications for early intervention. | Lubman DI et al. | β | 2008 | β |
| Early detection and intervention of psychosis. A review. | Salokangas RK et al. | β | 2008 | β |
| Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. | Konings M et al. | β | 2008 | β |
| Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. | Pelayo-TerΓ‘n JM et al. | β | 2008 | β |
| Gene-environment interplay between cannabis and psychosis. | Henquet C et al. | β | 2008 | β |
| [Induced psychiatric and somatic disorders to cannabis]. | Laqueille X et al. | β | 2008 | β |
| Long lasting consequences of cannabis exposure in adolescence. | Rubino T et al. | β | 2008 | β |
| Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. | Benyamina A et al. | β | 2008 | β |
| Polydrug use, cannabis, and psychosis-like symptoms. | Van Dam NT et al. | β | 2008 | β |
| Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. | Potter DJ et al. | β | 2008 | β |
| Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. | Cannon TD et al. | β | 2008 | β |
| Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. | Schneider M | β | 2008 | β |
| Putting 'addiction' back into psychiatry: the RANZCP Section of Addiction Psychiatry. | Lubman D et al. | β | 2008 | β |
| [Role of genetics in psychiatric treatment]. | Hamdani N et al. | β | 2008 | β |
| Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins. | Korhonen T et al. | β | 2008 | β |
| Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. | Pearlson GD et al. | β | 2008 | β |
| Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. | Baethge C et al. | β | 2008 | β |
| Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. | Corcoran CM et al. | β | 2008 | β |
| The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | Bambico FR et al. | β | 2008 | β |
| The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. | Hamdani N et al. | β | 2008 | β |
| The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? | DeLisi LE | β | 2008 | β |
| What is the mechanism whereby cannabis use increases risk of psychosis? | Luzi S et al. | β | 2008 | β |
| A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. | Boydell J et al. | β | 2007 | β |
| Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. | Karl T et al. | β | 2007 | β |
| Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. | Leweke FM et al. | β | 2007 | β |
| Beliefs of young people and their parents about the harmfulness of alcohol, cannabis and tobacco for mental disorders. | Lubman DI et al. | β | 2007 | β |
| Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. | Smesny S et al. | β | 2007 | β |
| Cannabis abuse and risk for psychosis in a prodromal sample. | Kristensen K et al. | β | 2007 | β |
| Cannabis and psychosis: what is the link? | Ben Amar M et al. | β | 2007 | β |
| Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. | Jockers-ScherΓΌbl MC et al. | β | 2007 | β |
| Cannabis, the mind and society: the hash realities. | Murray RM et al. | β | 2007 | β |
| Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. | Moore TH et al. | β | 2007 | β |
| Changing incidence of psychotic disorders among the young in Zurich. | Ajdacic-Gross V et al. | β | 2007 | β |
| Co-morbidity and cannabis use in a mental health trust in South East England. | Trathen B et al. | β | 2007 | β |
| Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. | de Beaurepaire R et al. | β | 2007 | β |
| Creating the cannabis user: a post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004-2005). | Acevedo B | β | 2007 | β |
| Endocannabinoid system and synaptic plasticity: implications for emotional responses. | Viveros MP et al. | β | 2007 | β |
| Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats. | Marco EM et al. | β | 2007 | β |
| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. | Boucher AA et al. | β | 2007 | β |
| Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. | Boucher AA et al. | β | 2007 | β |
| Hypothesis: social defeat is a risk factor for schizophrenia? | Selten JP et al. | β | 2007 | β |
| Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. | Garety PA et al. | β | 2007 | β |
| Intervening early to reduce developmentally harmful substance use among youth populations. | Lubman DI et al. | β | 2007 | β |
| [Motivational interviewing for cannabis users with psychotic disorders]. | Bonsack C et al. | β | 2007 | β |
| Neuroreceptor imaging studies in schizophrenia. | Frankle WG | β | 2007 | β |
| Outcomes of public concern in schizophrenia. | Kooyman I et al. | β | 2007 | β |
| Parent-teacher disagreement regarding behavioral and emotional problems in referred children is not a risk factor for poor outcome. | Ferdinand RF et al. | β | 2007 | β |
| Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. | Addington J et al. | β | 2007 | β |
| Personality differences in monozygotic twins discordant for cannabis use. | Vink JM et al. | β | 2007 | β |
| Predictors of cannabis use in men with and without psychosis. | Green B et al. | β | 2007 | β |
| Risk factors for schizophrenia--all roads lead to dopamine. | Di Forti M et al. | β | 2007 | β |
| Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. | Caton CL et al. | β | 2007 | β |
| Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. | Archie S et al. | β | 2007 | β |
| Substance use in a population-based clinic sample of people with first-episode psychosis. | Barnett JH et al. | β | 2007 | β |
| The contribution of social factors to the development of schizophrenia: a review of recent findings. | Cantor-Graae E | β | 2007 | β |
| The implications of recent findings on the link between cannabis and psychosis. | Pollack HA et al. | β | 2007 | β |
| The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. | Coulston CM et al. | β | 2007 | β |
| The toxicology of cannabis and cannabis prohibition. | Grotenhermen F | β | 2007 | β |
| Treatment of cannabis use disorders: a review of the literature. | Nordstrom BR et al. | β | 2007 | β |
| (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. | Ballon N et al. | β | 2006 | β |
| (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. | MartΓnez-Gras I et al. | β | 2006 | β |
| Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: a practical review for healthcare professionals providing clinical psychiatric genetics consultations. | Austin JC et al. | β | 2006 | β |
| A public health genetic approach for schizophrenia. | Danese A | β | 2006 | β |
| Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice. | Long LE et al. | β | 2006 | β |
| Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. | Laviolette SR et al. | β | 2006 | β |
| Cannabis and neurodevelopment: implications for psychiatric disorders. | Sundram S | β | 2006 | β |
| Cannabis use by children and young people. | McArdle PA | β | 2006 | β |
| Co-morbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in Southwest California Indians. | Gilder DA et al. | β | 2006 | β |
| Continuities and discontinuities in psychopathology between childhood and adult life. | Rutter M et al. | β | 2006 | β |
| Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. | Koethe D et al. | β | 2006 | β |
| Drug-induced psychosis associated with crystalline methamphetamine. | Dore G et al. | β | 2006 | β |
| [Epidemiology of schizophrenic disorders]. | Hautecouverture S et al. | β | 2006 | β |
| Gene-environment interactions in psychiatry: joining forces with neuroscience. | Caspi A et al. | β | 2006 | β |
| Gene-environment interplay and psychopathology: multiple varieties but real effects. | Rutter M et al. | β | 2006 | β |
| Genetic epidemiology of cannabis use, abuse and dependence: a comment on Agrawal and Lynskey (2006). | Kaprio J | β | 2006 | β |
| History of cannabis as a medicine: a review. | Zuardi AW | β | 2006 | β |
| Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. | Dubertret C et al. | β | 2006 | β |
| Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. | Wade DT et al. | β | 2006 | β |
| Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. | JanΓ©-Llopis E et al. | β | 2006 | β |
| Psychosis among substance users. | Thirthalli J et al. | β | 2006 | β |
| Reasons for cannabis use in psychosis. | Schofield D et al. | β | 2006 | β |
| Substance abuse in first-episode non-affective psychosis. | Larsen TK et al. | β | 2006 | β |
| Substance abuse in patients with schizophrenia. | Winklbaur B et al. | β | 2006 | β |
| Suicide in the Northern Territory, 1981-2002. | Measey MA et al. | β | 2006 | β |
| Temporal trends in rates of dual diagnoses at a Canadian addictions hospital over a five-year period. | Kolla NJ et al. | β | 2006 | β |
| What are the policy implications of the evidence on cannabis and psychosis? | Hall W et al. | β | 2006 | β |
| Adolescence, schizophrenia and drug abuse: a window of vulnerability. | van Nimwegen L et al. | β | 2005 | β |
| A tale of two jurisdictions. Can Australia and Canada learn from each other's experience with cannabis control? | Kisely S | β | 2005 | β |
| Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. | Schneider M et al. | β | 2005 | β |
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. | Ashton CH et al. | β | 2005 | β |
| Cannabis as a risk factor for psychosis: systematic review. | Semple DM et al. | β | 2005 | β |
| Cannabis consumption and risk of developing schizophrenia: myth or reality? | Di Forti M et al. | β | 2005 | β |
| Cannabis-induced extrapyramidalism in a patient on neuroleptic treatment. | RejΓ³n Altable C et al. | β | 2005 | β |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. | Arendt M et al. | β | 2005 | β |
| Cannabis potency in Europe. | King LA et al. | β | 2005 | β |
| Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed. | Addington J | β | 2005 | β |
| Cannabis use in sickle cell disease: a questionnaire study. | Howard J et al. | β | 2005 | β |
| Cannabis use predicts future psychotic symptoms, and vice versa. | Ferdinand RF et al. | β | 2005 | β |
| Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats. | Banjaw MY et al. | β | 2005 | β |
| Comments on risk for schizophrenia. | Weiser M et al. | β | 2005 | β |
| Comorbidity: cannabis and complexity. | Raphael B et al. | β | 2005 | β |
| Continuities between childhood and adult life. | Maughan B et al. | β | 2005 | β |
| Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. | Schneider M et al. | β | 2005 | β |
| Early detection of schizophrenia. | Drake RJ et al. | β | 2005 | β |
| Ebrii gignunt ebrios--One drunkard begets another: the genetics of alcohol dependence. | Ball D | β | 2005 | β |
| Environmentally mediated risks for psychopathology: research strategies and findings. | Rutter M | β | 2005 | β |
| Environmental risk factors for psychosis. | Dean K et al. | β | 2005 | β |
| Hallucinations in children and adolescents. | Sosland MD et al. | β | 2005 | β |
| Human studies of cannabinoids and medicinal cannabis. | Robson P | β | 2005 | β |
| Imaging of the brain cannabinoid system. | Lindsey KP et al. | β | 2005 | β |
| Impact of substance use on the onset and course of early psychosis. | Verdoux H et al. | β | 2005 | β |
| Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. | Pariante CM et al. | β | 2005 | β |
| Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies. | Hart CL | β | 2005 | β |
| Interpreting the association between cannabis use and increased risk for schizophrenia. | Weiser M et al. | β | 2005 | β |
| Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. | Isaac M et al. | β | 2005 | β |
| Is schizophrenia associated with narcolepsy? | Walterfang M et al. | β | 2005 | β |
| Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. | Caspi A et al. | β | 2005 | β |
| Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms. | Milani RM et al. | β | 2005 | β |
| Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. | Wade D et al. | β | 2005 | β |
| Predictors of schizophrenia--a review. | MΓ€ki P et al. | β | 2005 | β |
| Progress in the Prospective Study of the Schizophrenia Prodrome. | Fu EJ et al. | β | 2005 | β |
| Risk for schizophrenia--broadening the concepts, pushing back the boundaries. | Cannon M et al. | β | 2005 | β |
| Schizophrenia and migration: a meta-analysis and review. | Cantor-Graae E et al. | β | 2005 | β |
| Schizophrenia: an update and review. | Austin J | β | 2005 | β |
| Social defeat: risk factor for schizophrenia? | Selten JP et al. | β | 2005 | β |
| Structural violence and schizophrenia. | Kelly BD | β | 2005 | β |
| Tests of causal linkages between cannabis use and psychotic symptoms. | Fergusson DM et al. | β | 2005 | β |
| The potential adverse effects of habitual use of Catha edulis (khat). | Al-Habori M | β | 2005 | β |
| The safety of cannabinoids for the treatment of multiple sclerosis. | Smith PF | β | 2005 | β |
| The schizophrenia envirome. | van Os J et al. | β | 2005 | β |
| Two cases of "cannabis acute psychosis" following the administration of oral cannabis. | Favrat B et al. | β | 2005 | β |
| Understanding the genesis of psychotic disorder: issues in the prediction and prophylaxis of those at 'ultra-high risk'. | Mason OJ et al. | β | 2005 | β |
| Unravelling the complexity of attention-deficit hyperactivity disorder: a behavioural genomic approach. | Asherson P et al. | β | 2005 | β |
| What causes the onset of psychosis? | Broome MR et al. | β | 2005 | β |
| Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. | Arguello PA et al. | β | 2004 | β |
| Cannabis abuse and psychiatric disorder. | Tobin J | β | 2004 | β |
| Cannabis and psychopathology : update 2004. | Grover S et al. | β | 2004 | β |
| Cannabis and psychosis. | Dervaux A et al. | β | 2004 | β |
| Cannabis and psychosis. | Koenig JI et al. | β | 2004 | β |
| Cannabis and psychosis. | Luaute JP | β | 2004 | β |
| Cannabis and psychosis: accumulating evidence. | Fegusson DM | β | 2004 | β |
| Cannabis as a psychotropic medication. | Chaturvedi K | β | 2004 | β |
| How to prevent cannabis-induced psychological distress...in politicians. | Grotenhermen F | β | 2004 | β |
| Preventing crime by people with schizophrenic disorders: the role of psychiatric services. | Hodgins S et al. | β | 2004 | β |
| Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm. | Arendt M | β | 2004 | β |
| Schizophrenia. | Kelly BD et al. | β | 2004 | β |